Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling-Assisted Topical Treatments for Melasma
NCT07696806Phase 4Enrolling by invitation
- Sponsor
- Sameh Sarsik
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of metformin 1% gel, tranexamic acid, Avita HP in melasma, sponsored by Sameh Sarsik. Started Oct 2026; status: enrolling by invitation.
02
Drugs
metformin 1% geltranexamic acidAvita HP
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07696806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07696806.